RecruitingPhase 4NCT06499233
Efficacy and Safety of Prophylactic Treatment for Pneumocystis Jirovecii Pneumonia in Patients With Autoimmune Inflammatory Rheumatic Disease
Studying Pneumocystosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Tongji Hospital
- Principal Investigator
- Lingli DongTongji Hospital
- Intervention
- Trimethoprim/Sulfamethoxazole(drug)
- Enrollment
- 800 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2024 – 2026
Study locations (1)
- Tongji Hospital, Wuhan, Hubei, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06499233 on ClinicalTrials.govOther trials for Pneumocystosis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT04851015Low Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Jirovecii PneumoniaTodd C. Lee MD MPH FIDSA
- ACTIVE NOT RECRUITINGNCT06431958Droplet Digital PCR and PCR-free BIOSensors for the Detection of Resistance-associated SNPs in Pneumocystis JiroveciiUniversity Hospital, Brest
- RECRUITINGPHASE2NCT05835479Rezafungin for Treatment of Pneumocystis Pneumonia in HIV AdultsMundipharma Research Limited
- RECRUITINGNCT07269314Introduction of Polymerase Chain Reaction (PCR) in Microbiology and ParasitologyFondazione IRCCS Policlinico San Matteo di Pavia
- RECRUITINGNCT06691321Caspofungin for Pneumocystis Pneumonia in PLWHIV.Instituto Nacional de Enfermedades Respiratorias
- ENROLLING BY INVITATIONNANCT03856229Short-term Steroid Therapy in Patients With P. Jirovecii Pneumonia Due to HIV / AIDSCentro de Investigación en. Enfermedades Infecciosas, Mexico